ReP USP - Resultado da busca

Artigo de periodico
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis (2024)
Chapleau, Marianne; Joie, Renaud La; Yong, Keir; Agosta, Federica; Allen, Isabel Elaine; Apostolova, Liana; Best, John; Boon, Baayla D. C; Crutch, Sebastian; Grinberg, Lea Tenenholz
Fonte: Lancet neurology. Unidade: FM
Assuntos: DOENÇA DE ALZHEIMER, COMPROMETIMENTO COGNITIVO LEVE, DEMÊNCIA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAPLEAU, Marianne et al. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis. Lancet neurology, v. 23, n. 2, p. 168-177, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/59027. Acesso em: 01 dez. 2025.
APA
Chapleau, M., Joie, R. L., Yong, K., Agosta, F., Allen, I. E., Apostolova, L., et al. (2024). Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis. Lancet neurology, 23( 2), 168-177. doi:10.1016/S1474-4422(23)00414-3
NLM
Chapleau M, Joie RL, Yong K, Agosta F, Allen IE, Apostolova L, Best J, Boon BDC, Crutch S, Grinberg LT. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis [Internet]. Lancet neurology. 2024 ; 23( 2): 168-177.[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/59027
Vancouver
Chapleau M, Joie RL, Yong K, Agosta F, Allen IE, Apostolova L, Best J, Boon BDC, Crutch S, Grinberg LT. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis [Internet]. Lancet neurology. 2024 ; 23( 2): 168-177.[citado 2025 dez. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/59027
Artigo de periodico
Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project (2022)
Sajatovic, Martha; Dols, Annemiek; Rej, Soham; Almeida, Osvaldo P; Beunders, Alexandra J. M; Blumberg, Hilary P; Briggs, Farren B. S; Forester, Brent P; Patrick, Regan E; Forlenza, Orestes Vicente
Fonte: Bipolar disorders. Unidade: FM
Assuntos: TRANSTORNO BIPOLAR, COMPORTAMENTO, COMORBIDADE, DEPRESSÃO, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAJATOVIC, Martha et al. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project. Bipolar disorders, v. 24, n. 2, p. 195-206, 2022Tradução . . Disponível em: https://doi.org/10.1111/bdi.13119. Acesso em: 01 dez. 2025.
APA
Sajatovic, M., Dols, A., Rej, S., Almeida, O. P., Beunders, A. J. M., Blumberg, H. P., et al. (2022). Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project. Bipolar disorders, 24( 2), 195-206. doi:10.1111/bdi.13119
NLM
Sajatovic M, Dols A, Rej S, Almeida OP, Beunders AJM, Blumberg HP, Briggs FBS, Forester BP, Patrick RE, Forlenza OV. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project [Internet]. Bipolar disorders. 2022 ; 24( 2): 195-206.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1111/bdi.13119
Vancouver
Sajatovic M, Dols A, Rej S, Almeida OP, Beunders AJM, Blumberg HP, Briggs FBS, Forester BP, Patrick RE, Forlenza OV. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project [Internet]. Bipolar disorders. 2022 ; 24( 2): 195-206.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1111/bdi.13119
Artigo de periodico
Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes (2018)
Everett, Brendan M.; Nicolau, Jose C.; DONATH, Marc Y.; PRADHAN, Aruna D.; THUREN, Tom; PAIS, Prem; GLYNN, Robert J; LIBBY, Peter; RIDKER, Paul M.
Fonte: Journal of the american college of cardiology. Unidade: FM
Assuntos: ANTI-INFLAMATÓRIOS, DOENÇAS CARDIOVASCULARES, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EVERETT, Brendan M. et al. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. Journal of the american college of cardiology, v. 71, n. 21, p. 2392-2401, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.03.002. Acesso em: 01 dez. 2025.
APA
Everett, B. M., Nicolau, J. C., DONATH, M. Y., PRADHAN, A. D., THUREN, T., PAIS, P., et al. (2018). Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. Journal of the american college of cardiology, 71( 21), 2392-2401. doi:10.1016/j.jacc.2018.03.002
NLM
Everett BM, Nicolau JC, DONATH MY, PRADHAN AD, THUREN T, PAIS P, GLYNN RJ, LIBBY P, RIDKER PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes [Internet]. Journal of the american college of cardiology. 2018 ; 71( 21): 2392-2401.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1016/j.jacc.2018.03.002
Vancouver
Everett BM, Nicolau JC, DONATH MY, PRADHAN AD, THUREN T, PAIS P, GLYNN RJ, LIBBY P, RIDKER PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes [Internet]. Journal of the american college of cardiology. 2018 ; 71( 21): 2392-2401.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1016/j.jacc.2018.03.002
Artigo de periodico
Train-of-four recovery precedes twitch recovery during reversal with sugammadex in pediatric patients: A retrospective analysis (2018)
Carlos, Ricardo Vieira; Torres, Marcelo Luis Abramides; Boer, Hans Donald de
Fonte: Pediatric anesthesia. Unidade: FM
Assuntos: BLOQUEIO NERVOSO, PROCEDIMENTOS CIRÚRGICOS DO SISTEMA DIGESTÓRIO, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLOS, Ricardo Vieira e TORRES, Marcelo Luis Abramides e BOER, Hans Donald de. Train-of-four recovery precedes twitch recovery during reversal with sugammadex in pediatric patients: A retrospective analysis. Pediatric anesthesia, v. 28, n. 4, p. 342-346, 2018Tradução . . Disponível em: https://doi.org/10.1111/pan.13343. Acesso em: 01 dez. 2025.
APA
Carlos, R. V., Torres, M. L. A., & Boer, H. D. de. (2018). Train-of-four recovery precedes twitch recovery during reversal with sugammadex in pediatric patients: A retrospective analysis. Pediatric anesthesia, 28( 4), 342-346. doi:10.1111/pan.13343
NLM
Carlos RV, Torres MLA, Boer HD de. Train-of-four recovery precedes twitch recovery during reversal with sugammadex in pediatric patients: A retrospective analysis [Internet]. Pediatric anesthesia. 2018 ; 28( 4): 342-346.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1111/pan.13343
Vancouver
Carlos RV, Torres MLA, Boer HD de. Train-of-four recovery precedes twitch recovery during reversal with sugammadex in pediatric patients: A retrospective analysis [Internet]. Pediatric anesthesia. 2018 ; 28( 4): 342-346.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1111/pan.13343
Artigo de periodico
Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial (2018)
Corbalan, Ramon; Nicolau, Jose Carlos
Fonte: Journal of the american college of cardiology. Unidade: FM
Assuntos: ANTICOAGULANTES, FIBRILAÇÃO ATRIAL, ACIDENTE VASCULAR CEREBRAL, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORBALAN, Ramon e NICOLAU, Jose Carlos. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, v. 72, n. 13, p. 1466-1475, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.07.037. Acesso em: 01 dez. 2025.
APA
Corbalan, R., & Nicolau, J. C. (2018). Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, 72( 13), 1466-1475. doi:10.1016/j.jacc.2018.07.037
NLM
Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
Vancouver
Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
Artigo de periodico
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) (2018)
Giugliano, Robert P.; Nicolau, Jose Carlos
Fonte: Circulation. Unidade: FM
Assuntos: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIUGLIANO, Robert P. e NICOLAU, Jose Carlos. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, v. 137, n. 15, p. 1571-0, 2018Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.117.030950. Acesso em: 01 dez. 2025.
APA
Giugliano, R. P., & Nicolau, J. C. (2018). Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, 137( 15), 1571-0. doi:10.1161/CIRCULATIONAHA.117.030950
NLM
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Vancouver
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Artigo de periodico
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract (2018)
Mach, Francois; Santos, Raul D
Fonte: European heart journal. Unidade: FM
Assuntos: INSUFICIÊNCIA RENAL CRÔNICA, MORTALIDADE, DIABETES MELLITUS, ESTUDOS RANDOMIZADOS, PLACEBOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACH, Francois e SANTOS, Raul D. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. European heart journal, v. 39, n. 27, p. 2526-+, 2018Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehy182. Acesso em: 01 dez. 2025.
APA
Mach, F., & Santos, R. D. (2018). Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. European heart journal, 39( 27), 2526-+. doi:10.1093/eurheartj/ehy182
NLM
Mach F, Santos RD. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract [Internet]. European heart journal. 2018 ; 39( 27): 2526-+.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1093/eurheartj/ehy182
Vancouver
Mach F, Santos RD. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract [Internet]. European heart journal. 2018 ; 39( 27): 2526-+.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1093/eurheartj/ehy182
Artigo de periodico
World Heart Federation Cholesterol Roadmap (2017)
Murphy, A.; Santos Filho, Raul Dias dos
Fonte: Global heart. Unidade: FM
Assuntos: COLESTEROL, DOENÇAS CARDIOVASCULARES, POLÍTICAS PÚBLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MURPHY, A. e SANTOS FILHO, Raul Dias dos. World Heart Federation Cholesterol Roadmap. Global heart, v. 12, n. 3, p. 179-197.e5, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.gheart.2017.03.002. Acesso em: 01 dez. 2025.
APA
Murphy, A., & Santos Filho, R. D. dos. (2017). World Heart Federation Cholesterol Roadmap. Global heart, 12( 3), 179-197.e5. doi:10.1016/j.gheart.2017.03.002
NLM
Murphy A, Santos Filho RD dos. World Heart Federation Cholesterol Roadmap [Internet]. Global heart. 2017 ; 12( 3): 179-197.e5.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1016/j.gheart.2017.03.002
Vancouver
Murphy A, Santos Filho RD dos. World Heart Federation Cholesterol Roadmap [Internet]. Global heart. 2017 ; 12( 3): 179-197.e5.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1016/j.gheart.2017.03.002
Artigo de periodico-carta/editorial
Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary (2017)
Santos Filho, Raul Dias dos
Fonte: Current opinion in lipidology. Unidade: FM
Assuntos: GENÉTICA MÉDICA, EPIDEMIOLOGIA, BIOLOGIA CELULAR, ESTUDOS RANDOMIZADOS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos. Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary. Current opinion in lipidology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/MOL.0000000000000460. Acesso em: 01 dez. 2025. , 2017
APA
Santos Filho, R. D. dos. (2017). Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary. Current opinion in lipidology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. doi:10.1097/MOL.0000000000000460
NLM
Santos Filho RD dos. Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary [Internet]. Current opinion in lipidology. 2017 ; 28( 6): 522-523.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1097/MOL.0000000000000460
Vancouver
Santos Filho RD dos. Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary [Internet]. Current opinion in lipidology. 2017 ; 28( 6): 522-523.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1097/MOL.0000000000000460
Artigo de periodico
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD (2017)
Charytan, David M.; Burdmann, Emmanuel de Almeida
Fonte: American journal of kidney diseases. Unidade: FM
Assuntos: FALÊNCIA RENAL CRÔNICA, DOENÇAS CARDIOVASCULARES, DIABETES MELLITUS, INFARTO DO MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHARYTAN, David M. e BURDMANN, Emmanuel de Almeida. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. American journal of kidney diseases, v. 70, n. 4, p. 522-531, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/21785. Acesso em: 01 dez. 2025.
APA
Charytan, D. M., & Burdmann, E. de A. (2017). ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. American journal of kidney diseases, 70( 4), 522-531. doi:10.1053/j.ajkd.2017.04.018
NLM
Charytan DM, Burdmann E de A. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD [Internet]. American journal of kidney diseases. 2017 ; 70( 4): 522-531.[citado 2025 dez. 01 ] Available from: http://observatorio.fm.usp.br/handle/OPI/21785
Vancouver
Charytan DM, Burdmann E de A. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD [Internet]. American journal of kidney diseases. 2017 ; 70( 4): 522-531.[citado 2025 dez. 01 ] Available from: http://observatorio.fm.usp.br/handle/OPI/21785
Artigo de periodico
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 (2017)
Akinyemiju, Tomi; Benseñor, Isabela Judith Martins
Fonte: Jama oncology. Unidade: FM
Assuntos: HEPATOPATIAS, MORTALIDADE, NEOPLASIAS HEPÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKINYEMIJU, Tomi e BENSEÑOR, Isabela Judith Martins. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015. Jama oncology, v. 3, n. 12, p. 1683-1691, 2017Tradução . . Disponível em: https://doi.org/10.1001/jamaoncol.2017.3055. Acesso em: 01 dez. 2025.
APA
Akinyemiju, T., & Benseñor, I. J. M. (2017). The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015. Jama oncology, 3( 12), 1683-1691. doi:10.1001/jamaoncol.2017.3055
NLM
Akinyemiju T, Benseñor IJM. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 [Internet]. Jama oncology. 2017 ; 3( 12): 1683-1691.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1001/jamaoncol.2017.3055
Vancouver
Akinyemiju T, Benseñor IJM. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 [Internet]. Jama oncology. 2017 ; 3( 12): 1683-1691.[citado 2025 dez. 01 ] Available from: https://doi.org/10.1001/jamaoncol.2017.3055

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Título da fonte

Agência de fomento